Sino Biopharmaceutical Limited

HKEX:1177.HK

3.58 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Revenue 26,199.40928,780.41226,861.35623,647.22424,234.0320,888.58414,819.30214,170.15212,184.0649,898.2287,736.8636,704.5674,679.8083,482.3142,855.8692,009.4991,090.687736.636787.0241,119.076876.117734.725572.98416.847325.52
Cost of Revenue 4,989.8775,795.515,332.0955,182.324,926.2684,196.9323,090.6252,946.9712,721.232,335.3741,741.2491,386.4631,005.937668.876563.167416.694192.759139.163145.125198.496179.868154.185107.64988.21987.466
Gross Profit 21,209.53222,984.90221,529.26118,464.90419,307.76216,691.65211,728.67711,223.1819,462.8337,562.8545,995.6145,318.1043,673.8722,813.4382,292.7011,592.804897.928597.473641.898920.579696.249580.54465.331328.628238.054
Gross Profit Ratio 0.810.7990.8010.7810.7970.7990.7910.7920.7770.7640.7750.7930.7850.8080.8030.7930.8230.8110.8160.8230.7950.790.8120.7880.731
Reseach & Development Expenses 4,402.9734,332.63,747.0782,626.7092,398.7122,090.5671,595.3121,373.1151,095.697863.13695.547435.3580000000000000
General & Administrative Expenses 1,873.2842,204.6972,185.2342,655.9262,589.2192,189.501986.9451,087.5381,033.365659.676498.781586.1192,471.9931,889.598367.0171,040.83144.93122.131115.404168.465123.91189.41883.42558.28944.23
Selling & Marketing Expenses 9,193.35110,359.3110,518.3938,972.6359,319.5418,078.5445,917.8795,705.5024,938.2684,272.13,449.1192,945.241001,133.5780471.912328.605323.324438.297360.86328.39252.154173.572120.124
SG&A 11,066.63512,564.00712,703.62711,628.56111,908.7610,268.0456,904.8246,793.045,971.6334,931.7763,947.93,531.362,471.9931,889.5981,500.5951,040.83616.842450.736438.729606.762484.771417.808335.579231.861164.354
Other Expenses 176.5784,384.5964,482.195-94.515-90.96235.8430.55633.39417.89123.28712.91820.822383.511-9.12886.58615.397-50.346-31.338-42.10152.3916.146-1.193-2.03-2.6324.359
Operating Expenses 15,423.81816,948.60317,185.82214,160.75514,216.5112,372.1768,466.2498,334.7717,080.6165,738.7284,618.2363,968.6042,855.5041,880.4691,587.1811,056.227600.867359.003482.681648.39527.624435.456338.445235.132168.713
Operating Income 5,439.2376,690.30718,860.4464,888.3945,808.3254,973.4154,174.4284,714.4422,678.3112,005.1072,195.2291,446.835815.032932.969705.521536.578373.236238.47159.217283.213178.561145.084126.88593.49693.793
Operating Income Ratio 0.2080.2320.7020.2070.240.2380.2820.3330.220.2030.2840.2160.1740.2680.2470.2670.3420.3240.2020.2530.2040.1970.2210.2240.288
Total Other Income Expenses Net -29.331-911.703-287.773124.65-224.5036,455.66621.411-77.259205.528234.85128.696-6.38-9.137-6.162-1.624-8.043-50.105-32.843-42.10152.3916.146-1.193-52.684-38.067-28.413
Income Before Tax 5,409.9065,778.60418,572.6735,013.0445,583.82211,429.0814,195.8393,351.7452,883.8392,239.9581,669.4841,440.455805.895926.807703.897528.534320.68205.627117.117335.603184.706143.891124.85590.86465.379
Income Before Tax Ratio 0.2060.2010.6910.2120.230.5470.2830.2370.2370.2260.2160.2150.1720.2660.2460.2630.2940.2790.1490.30.2110.1960.2180.2180.201
Income Tax Expense 797.267775.9861,957.88672.377889.448696.236542.292496.966446.22351.964277.049299.116134.769194.432118.885104.12831.82522.16619.06131.89824.84218.2278.6857.1732.78
Net Income 2,331.9395,002.61814,608.4124,340.6674,694.3749,046.3472,170.9511,713.1541,489.4411,210.02810.135717.232374.558483.124349.505262.051210.173141.5531,720.255179.34687.0260.88365.51648.25538.148
Net Income Ratio 0.0890.1740.5440.1840.1940.4330.1460.1210.1220.1220.1050.1070.080.1390.1220.130.1930.1922.1860.160.0990.0830.1140.1160.117
EPS 0.10.270.780.230.250.490.130.0980.0890.0730.0490.0430.0220.030.0230.0170.0140.0090.110.0130.0070.020.0220.0180.016
EPS Diluted 0.10.260.730.230.250.490.130.0980.0890.0730.0490.0430.0220.030.0230.0170.0140.0090.110.0120.0060.0180.020.0180.016
EBITDA 7,026.2287,737.29119,853.0026,543.237,274.3536,149.5394,517.8173,782.0963,220.1612,446.3441,815.7791,582.696925.0561,004.76759.395573.156350.185229.935189.804306.798196.033159.626126.88593.49669.341
EBITDA Ratio 0.2680.2690.7390.2770.30.2940.3050.2670.2640.2470.2350.2360.1980.2890.2660.2850.3210.3120.2410.2740.2240.2170.2210.2240.213